Mari Posner

Person

Laguna Niguel, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Therapeutic substituted cyclopentanes
- Patent number 9,765,065
- Issue date Sep 19, 2017
- Allergan, Inc.
- David W. Old
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic substituted cyclopentanes
- Patent number 9,591,935
- Issue date Mar 14, 2017
- Allergen, Inc.
- David W. Old
- A47 - FURNITURE DOMESTIC ARTICLES OR APPLIANCES COFFEE MILLS SPICE MILLS SUCT...
Information Patent Grant
Substituted cyclopentanes having prostaglandin activity
- Patent number 8,487,091
- Issue date Jul 16, 2013
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 8,193,373
- Issue date Jun 5, 2012
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 7,964,634
- Issue date Jun 21, 2011
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic compounds
- Patent number 7,960,378
- Issue date Jun 14, 2011
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...
- Patent number 7,514,462
- Issue date Apr 7, 2009
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Patent number 7,223,746
- Issue date May 29, 2007
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,3,4-substituted cyclopentanones as therapeutic agents
- Patent number 7,183,324
- Issue date Feb 27, 2007
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...
- Patent number 7,022,726
- Issue date Apr 4, 2006
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EP4 agonists as agents for lowering intraocular pressure
- Patent number 6,956,057
- Issue date Oct 18, 2005
- Allergan, Inc.
- David F. Woodward
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...
- Patent number 6,767,920
- Issue date Jul 27, 2004
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...
- Patent number 6,710,072
- Issue date Mar 23, 2004
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...
- Patent number 6,586,462
- Issue date Jul 1, 2003
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...
- Patent number 6,538,018
- Issue date Mar 25, 2003
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents fo...
- Patent number 6,410,591
- Issue date Jun 25, 2002
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Patent number 6,376,533
- Issue date Apr 23, 2002
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...
- Patent number 6,359,181
- Issue date Mar 19, 2002
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivat...
- Patent number 6,307,092
- Issue date Oct 23, 2001
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...
- Patent number 6,248,783
- Issue date Jun 19, 2001
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC SUBSTITUTED CYCLOPENTANES
- Publication number 20170144999
- Publication date May 25, 2017
- Allergan, Inc.
- David W. Old
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20100063303
- Publication date Mar 11, 2010
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20090275646
- Publication date Nov 5, 2009
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20090239930
- Publication date Sep 24, 2009
- Allergan, Inc.
- Mark HOLOBOSKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY
- Publication number 20090227573
- Publication date Sep 10, 2009
- Allergan, Inc.
- Mark Holoboski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
omega-Cycloalkyl 17-Heteroaryl Prostaglandin E2 Analogs as EP2-Rece...
- Publication number 20070219262
- Publication date Sep 20, 2007
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,3,4-substituted cyclopentanones as therapeutic agents
- Publication number 20060111430
- Publication date May 25, 2006
- Allergan, Inc.
- Yariv Donde
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of inflammatory bowel disease
- Publication number 20050222094
- Publication date Oct 6, 2005
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor a...
- Publication number 20050113338
- Publication date May 26, 2005
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Publication number 20040106580
- Publication date Jun 3, 2004
- ALLERGAN INC.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EP4 agonists as agents for lowering intraocular pressure
- Publication number 20040102499
- Publication date May 27, 2004
- Allergan, Inc.
- David F. Woodward
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...
- Publication number 20030144254
- Publication date Jul 31, 2003
- Allergan Sales, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Publication number 20030130239
- Publication date Jul 10, 2003
- Allergan, Inc.
- Robert M. Burk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for...
- Publication number 20030027853
- Publication date Feb 6, 2003
- Allergan Sales, Inc.
- Robert M. Burk
- Y10 - TECHNICAL SUBJECTS COVERED BY FORMER USPC
Information Patent Application
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...
- Publication number 20020187961
- Publication date Dec 12, 2002
- Robert M. Burk
- C07 - ORGANIC CHEMISTRY

Mari Posner

Person

Patents Grantslast 30 patents

Therapeutic substituted cyclopentanes

Therapeutic substituted cyclopentanes

Substituted cyclopentanes having prostaglandin activity

Therapeutic compounds

Therapeutic compounds

Therapeutic compounds

ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...

Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

2,3,4-substituted cyclopentanones as therapeutic agents

ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor...

EP4 agonists as agents for lowering intraocular pressure

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...

&#x03A9;-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...

&#x03C9;-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...

3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents fo...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...

Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivat...

Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivati...

Patents Applicationslast 30 patents

THERAPEUTIC SUBSTITUTED CYCLOPENTANES

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

THERAPEUTIC COMPOUNDS

SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY

omega-Cycloalkyl 17-Heteroaryl Prostaglandin E2 Analogs as EP2-Rece...

2,3,4-substituted cyclopentanones as therapeutic agents

Treatment of inflammatory bowel disease

Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor a...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

EP4 agonists as agents for lowering intraocular pressure

3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents f...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for...

Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-rece...

Ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...

ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-r...